Sharesource 2.0 Telehealth Platform Launch by Baxter

“While the global patient population requiring dialysis is growing, the number of clinicians and their resources are not increasing,” says Laura Angelini, general manager, of Baxter Renal Care business.

Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

3/19/19: The announcement was made at the International Symposium on Intensive Care and Emergency Medicine this week.

Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU

2/11/19: “The ICU requires coordinated care among specialists and nurses, further complicated by the need to manage data streams from numerous medical devices,” said Brian Tufts, Baxter’s lead for Acute Therapies in the U.S. “When customers use technology to streamline connectivity of Prismaflex to their IT systems, busy nurses are no longer tasked with manually charting treatment data. We are excited about this development as we work to create digital health solutions to help our customers turn data into meaningful insights to improve patient care.”

Baxter Announces 5 Million Home Dialysis Treatments Managed Globally with Sharesource Remote Patient Management

1/17/19: Baxter’s Sharesource remote patient management platform has logged more than 5 million home peritoneal dialysis treatments globally; milestone is evidence that smarter, more effective innovation is enhancing renal care.

Floseal Surgical Hemostat Quantifies Clinical and Healthcare Resource Outcomes in Spine Surgery Cases Reported in New Data

9/27/18: “This data suggests that the use of Floseal as a primary adjunctive hemostat during spine surgery correlates with measurable improvements for hospital administrators and surgeons such as length of stay and blood loss. This reinforces my belief that the choice of proper adjunctive hemostatic agent is a key component to driving down costs and complications for my patients,” said Nitin Khanna, M.D., minimally invasive orthopedic spine surgeon from Orthopedic Specialists of Northwest Indiana and co-author on the study published in Hospital Practice.

Baxter Launches First 3-in-1 Set for Use in Continuous Renal Replacement Therapy and Sepsis Management Protocols

HOME Baxter International Inc. (NYSE: BAX) announced today the commercial launch of a new indication for the company’s oXiris set, which can now...

Data on Telehealth’s Role in Improving Peritoneal Dialysis Patient Care at ERA-EDTA 2017

Physicians using SHARESOURCE remote patient management – a telehealth platform – have more accurate and timely visibility to their patients’ home therapy adherence Remote patient...

Baxter Presents Data at ISPOR Annual Meeting with Focus on Helping Hospitals Improve Patient Care

Baxter presents results of seven studies at ISPOR 2017, one of the largest health economics and outcomes research (HEOR) conferences Studies analyzed critical areas of...

Baxter Launches New AK 98 Hemodialysis System Designed to Help Providers Reach Treatment Goals

“We designed our new AK 98 system specifically to help dialysis providers minimize the operational challenges associated with hemodialysis,” said Laura Angelini, general manager,...

Baxter Named One of America’s Best Employers by Forbes Magazine for Third Consecutive Year

“Baxter is committed to providing an engaging, rewarding work experience that reflects the passion our employees bring to our mission of saving and sustaining...

Baxter Achieves Regulatory Milestone for New Peritoneal Dialysis Technology

Company States: Innovative home dialysis solution generation system designed to enhance patients’ therapy experience New system may reduce barriers and offer more patients access to...

Baxter Unveils Design Enhancements to FLOSEAL and TISSEEL Hemostatic Agents at AORN Meeting

  Baxter Unveils Design Enhancements to FLOSEAL and TISSEEL Hemostatic Agents at AORN Meeting New design for preparation of FLOSEAL enhances patient safety and accelerates...

Must Read

New Study Validates Rigorous Safety Measures Needed To Reduce Mercury Exposure During Dental Amalgam Filling Removal

"For decades, our non-profit organization has been concerned about this issue and collected research about amalgam fillings, all of which contain approximately 50% mercury, a known neurotoxin," explains IAOMT President Michael Rehme, DDS, NMD.  "Based on this science, we have strongly recommended that safety measures be enacted for dental procedures involving these silver-colored fillings, and we have also intensely advocated for the end of dental amalgam usage."